Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,662 | -1,033 | -2,628 | -2,194 | -1,410 |
| Depreciation Amortization | 273 | 273 | N/A | N/A | N/A |
| Accounts receivable | 219 | 714 | -26 | 903 | -248 |
| Other Working Capital | -452 | -110 | 5 | 773 | -118 |
| Other Operating Activity | -133 | -664 | 206 | -603 | 507 |
| Operating Cash Flow | $-1,755 | $-820 | $-2,443 | $-1,121 | $-1,269 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,000 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 20 | N/A |
| Common Stock Issued | 2,005 | 2,005 | 20 | N/A | N/A |
| Other Financing Activity | 4,165 | 4,165 | 0 | 0 | 0 |
| Financing Cash Flow | $6,170 | $6,170 | $1,020 | $20 | $N/A |
| Beginning Cash Position | 94 | 94 | 1,517 | 1,517 | 1,517 |
| End Cash Position | 4,509 | 5,444 | 94 | 416 | 248 |
| Net Cash Flow | $4,415 | $5,350 | $-1,423 | $-1,101 | $-1,269 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,755 | -820 | -2,443 | -1,121 | -1,269 |
| Free Cash Flow | -1,755 | -820 | -2,443 | -1,121 | -1,269 |